Sensei Bio logo

Sensei Bio

We follow the immune system’s teachings to discover new treatments that inspire the body to fight cancer.

32 employees · est. 1999 · Rockville, United States

VS
Transgene logo

Transgene

Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IO™ and myvac®

213 employees · est. 1979 · Illkirch-graffenstaden, Fran...

Transgene is the older company (1999 vs 1979); Transgene is the larger of the two.

Side-by-Side Comparison

Sensei Bio Transgene
Founded
1999 1979 older
Headquarters
Rockville, United States Illkirch-graffenstaden, France
Employees
32 213 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Manufacturing, Pharmaceutical
Funding Stage
Series B Post Ipo Equity
Total Funding
$58.50M $82.50M
Funding Rounds
2 4
Services
Research and Development of Cancer Therapeutics, Clinical Trials for Cancer Treatments, Multi-node Inhibition Therapies Development of personalized therapeutic vaccines, Design and implementation of oncolytic virus therapies, Research and development in immunotherapy, Advanced engineering technology applications
Target Customers
Cancer Patients, Oncologists, Healthcare Providers Cancer patients, Pharmaceutical companies, Biotechnology researchers, Healthcare providers
Taxonomy
Immunotherapy, Cancer Treatment, Drug Discovery, Clinical-stage Biotech, Cancer Immunotherapies, Tumor Microenvironment, Next-generation Therapies, Biologics, ImmunoPhage Platform, Biology, Immunology, Oncology, Therapeutics, Clinical Research Immunotherapy, Cancer Treatment, Clinical-stage Products, Invir.IO™ Platform, Myvac® Platform, Biopharmaceutical, Immunotherapeutic Products, Chronic Infectious Diseases, Clinical Trials, Clinical Batch Manufacturing, Oncology
Website
senseibio.com transgene.fr
Sensei Bio logo

About Sensei Bio

Sensei Bio, founded in 1999, is a pioneering player in the Biotechnology and Life Sciences sectors, focused on developing cutting-edge immuno-oncology therapies. Their compelling slogan, "We follow the immune system’s teachings to discover new treatments that inspire the body to fight cancer," succi...

Transgene logo

About Transgene

Transgene is a pioneering biotechnology company established in 1979, headquartered in France. The company focuses on advancing cancer treatment through its innovative immunotherapy solutions. With a slogan promoting "Immunotherapy against cancer," Transgene offers four clinical-stage products backed...

We will tell you when either one moves

BounceWatch watches Sensei Bio and Transgene for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Sensei Bio and Transgene — by email.

Frequently Asked Questions

Sensei Bio — We follow the immune system’s teachings to discover new treatments that inspire the body to fight cancer.. Transgene — Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IO™ and myvac®. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Sensei Bio has raised $58.50M while Transgene has raised $82.50M.
Sensei Bio and Transgene operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Sensei Bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Sensei Bio on 12 Sep 2024, and Transgene on 17 Sep 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy